The bill mandates that the Alabama Medicaid Agency provide coverage for specific noninvasive colorectal cancer screening tests that receive a grade A or B from the United States Preventive Services Task Force. The covered tests include the guaiac fecal occult blood test (gFOBT), the fecal immunochemical test (FIT), and the multi-target stool DNA test (sDNA-FIT). Additionally, the bill requires that a colonoscopy be covered if it is performed following a positive result from one of these screening tests.

This new provision will be in effect for two years from the date the act becomes effective, which is set for October 1, 2025. The bill also includes a provision for its repeal after the two-year period. The language inserted into the current law includes the requirement for coverage of the specified tests and colonoscopy, while no deletions from existing law are noted in the summary provided.